EphMRA Asia Conference
Singapore 13-14 November 2013
We are delighted to once again be attending at the annual EphMRA Asia Conference in November. Associate Director Pei Li Teh will be presenting a paper entitled “Using patient engagement to remove the roadblocks to effective treatment” with a market research associate from Takeda. Takeda has a strong portfolio focused on interrupting the cardiovascular continuum and is committed to improving the treatment of chronic disease. Recognising that there are many possible roadblocks requiring intervention along the patient journey, they have developed programmes aimed at those stakeholders who can positively influence the medical outcome.